Market closed
Aytu BioPharma Inc./$AYTU
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.
Ticker
$AYTU
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
-
Website
AYTU Metrics
BasicAdvanced
$6.4M
-
-$1.90
-1.45
-
Price and volume
Market cap
$6.4M
Beta
-1.45
52-week high
$1.35
52-week low
$0.95
Average daily volume
37K
Financial strength
Current ratio
0.984
Quick ratio
0.715
Long term debt to equity
36.044
Total debt to equity
55.713
Interest coverage (TTM)
-1.15%
Management effectiveness
Return on assets (TTM)
-2.51%
Return on equity (TTM)
-22.74%
Valuation
Price to revenue (TTM)
0.079
Price to book
0.21
Price to tangible book (TTM)
-0.33
Price to free cash flow (TTM)
11.434
Growth
Revenue change (TTM)
-14.22%
Earnings per share change (TTM)
-50.53%
3-year revenue growth (CAGR)
-1.97%
3-year earnings per share growth (CAGR)
-70.17%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Aytu BioPharma Inc. stock?
Aytu BioPharma Inc. (AYTU) has a market cap of $6.4M as of April 16, 2025.
What is the P/E ratio for Aytu BioPharma Inc. stock?
The price to earnings (P/E) ratio for Aytu BioPharma Inc. (AYTU) stock is 0 as of April 16, 2025.
Does Aytu BioPharma Inc. stock pay dividends?
No, Aytu BioPharma Inc. (AYTU) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next Aytu BioPharma Inc. dividend payment date?
Aytu BioPharma Inc. (AYTU) stock does not pay dividends to its shareholders.
What is the beta indicator for Aytu BioPharma Inc.?
Aytu BioPharma Inc. (AYTU) has a beta rating of -1.45. This means that it has an inverse relation to market volatility.